The Walter and Eliza Hall Institute (WEHI) has received grants totalling $450,000 from the Victorian Cancer Agency to support its research into BH3 mimetics cancer drugs and the creation of an information sharing portal focussed on rare cancers.
Melbourne biotech Patrys announced today that it has secured funding of up to $15 million over the next three years to develop its lead natural human anti-body candidates into treatments for various cancers.
Beleaguered Victorian biotech Sigma Pharmaceuticals has appointed former group treasurer Jeff Sells as its new CFO.
The Garvan Institute has named two of its top upcoming scientists as Young 2010 Garvan Fellows with each to receive a grant of $25,000 to advance their research looking into treatments for cancer and diabetes.
Music training may bring about biological changes in the brain that could enhance music processing and even transfer to other domains.
More than 2000 of the world’s leading experts on soil will converge on Brisbane next month for the 19th World Congress of Soil Science.
PricewaterhouseCoopers has released its BioForum report for the fourth quarter FY10 showing a fall of 9.5 percent for the local Life Sciences Index, which performed slightly better than the broader market.
Melbourne biotech Sigma Pharmaceuticals has assured shareholders that it is trying to negotiate a better deal than the revised $0.55 a share offered for the company by South African generics producer Aspen Pharmacare Holdings.
Pharmaceutical companies continue to be heavily reliant on sales form their mature drugs, while investment in R&D and clinical trials for their successors has shown a marked decline.
Merck has stumped up $500,000 to fund a new research centre at the University of Sydney designed to help Australia benefit from U.S approaches to innovation.
Price Waterhouse Coopers has released its quarterly Bioforum report showing that the Australian life sciences sector is outperforming the wider market despite a fairly slow start to the year.
California’s MP Biomedicals has acquired the assets of Auckland-based protein biologics manufacturing company ICPbio in deal estimated to be worth.
Federal innovation minister Kim Carr has affirmed that the government will seek to have its new R&D Tax Credit apply retrospectively from July 1 this year.
In this final part of the roundtable discussion the panellists address the role of government in commercialisation and then provide their closing comments on how we can improve the system in Australia.
A who’s who of Australian scientists have been tapped to direct the research of the new South Australian Health and Medical Research Institute (SAHMRI) in Adelaide.